Patients with myelodysplastic neoplasms (MDS) suffer from a disruption in the healthy maturation of blood cells in their bone marrow. This can lead to anemia, infections and an increased risk of ...

Blood disorders known as myelodysplastic syndromes/neoplasms (MDS) are difficult to diagnose – and are commonly misdiagnosed – putting patients at increased risk for treatment mistakes and ...

For this reason, current evidence-based recommendations from international medical societies and the German Society of Hematology and Medical Oncology (DGHO) (Myelodysplastic Neoplasms ...

The models were tested ... The risk for COVID-19 hospitalization is low in adults with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), but these individuals have a high mortality ...